Loading...

Archive

    02 June 2017, Volume 33 Issue 6 Previous Issue    Next Issue

    For Selected: Toggle Thumbnails
    Comparisons of global postpartum hemorrhage guidelines.
    LIU Xing-hui,CHEN Meng
    2017, 33(6): 556-559.  DOI: 10.19538/j.fk2017060102
    Abstract ( )  

    Postpartum hemorrhage(PPH)is the leading cause of maternal death worldwide.Guidelines for the diagnosis and treatment of PPH are of great importance to provide standard management guidance and to reduce maternal mortality rate.Here we compare Chinese PPH guideline with PPH guidelines from other countries,in order to arouse additional attention to the management of PPH in obstetricians.

    International guidelines of hypertensive disorders of pregnancy and clinical practice in China.
    GOU Wen-li,XUE Yan
    2017, 33(6): 559-563.  DOI: 10.19538/j.fk2017060103
    Abstract ( )  

    Hypertensive disorders of pregnancy(HDP)is a serious disease threatening the health of mothers and children in the world.With the increase of experience in diagnosis and treatment,international and Chinese HDP guidelines have been updated and revised continuously.This paper intends to compare and analyze the main different points of diagnosis,treatment and prevention in various international HDP guidelines,based on the clinical pratice activities and principles under the guidence of China HDP guidelines.

    International guideline and national consensus of non-invasive prenatal testing.
    LIU Jun-tao
    2017, 33(6): 564-567.  DOI: 10.19538/j.fk2017060104
    Abstract ( )  

    With the implementation of second generation sequencing in prenatal screening,guidelines and consensuses were published and updated by many academic committees in the world.National Health and Family Planning Commission of the People’s Republic of China launched national regulation and consensus of fetal cell free DNA in prenatal screening and diagnosis,based on the international and domestic clinical trials,and the expertise.The regulation and consensus included requirements,indication,clinical procedure,testing procedure and quality control of cell free DNA in prenatal screening,thus made the cornerstone of the techinique in clinical practice in China.

    Talk about WHO antenatal care guideline(2016)based on practice in China.
    YUAN Yu,QI Hong-bo
    2017, 33(6): 567-571.  DOI: 10.19538/j.fk2017060105
    Abstract ( )  

    In 2016,the World Health Organization(WHO) released a new edition of the antenatal care guideline based on the level of healthcare of the whole world,especially the developing countries.It offered thirty-nine suggestions on five aspects of antenatal care,and updated some viewpoints through high-quality scientific evidence.Aimed at improving the antenatal care of China,this article analyzed the similarities and differences between WHO antenatal care guideline and the China’s practice.

    Guideline for prevention of the primary cesarean in promoting vaginal delivery.
    BIAN Zheng,YING Hao
    2017, 33(6): 571-575.  DOI: 10.19538/j.fk2017060106
    Abstract ( )  

    Although cesarean delivery is considered to be one of the most important ways in managing complications,dystocia and intrauterine asphyxia,the rapid increase in cesarean section does not decrease the maternal and neonatal morbidity or mortality.Actually,the complications in cesarean are increasing.The purpose of this article is to review the risks of cesarean delivery and analyze the prevention of primary cesarean in 7 aspects:antenatal management,individual induction,delivery support,new labor process and fetal heart rate management,external cephalic version for breech presentation and vaginal birth after cesarean,in order to promote the vaginal delivery.

    Obesity in pregnancy:the international development and practice in China.
    ZHAO Xin,JIN Chun-hua
    2017, 33(6): 575-578.  DOI: 10.19538/j.fk2017060107
    Abstract ( )  

    The prevalence of obesity worldwide is increasing in recent years.Obesity in pregnancy increasing ,too.It is well recognised that maternal obesity is associated with an increased risk of antenatal,peri-partum and neonatal complications.Obesity increases the rate of cesarean section and has influence on the  long-term health of offsprings.The management of obesity during pregnancy is essential,and management should begin before conception and continue through the postpartum period.

    Venous thromboembolic disease in pregnancy:treatment,prevention and practice in China.
    GU Wei-rong,LI Xiao-tian
    2017, 33(6): 578-584.  DOI: 10.19538/j.fk2017060108
    Abstract ( )  

    Pregnancy and the puerperium are well-established risk factors for venous thromboembolic disease(VTE).Imaging studies,such as compression ultrasonography,V/Q scan and CTPA,play a major role in confirming suspected DVT or PE in pregnant women.LMWHs are recommended as first-line anticoagulants for thromboprophylaxis and treatment of VTE during pregnancy.If VTE occurs at term,delivery should be attended by an experienced multidisciplinary team.In recent years,the number of pregnant women with VTE increases in China,but there is a lack of actual morbidity and studies about VTE prevention and treatment. There is an urgent need for setting up prevention and multidisciplinary management strategies for Chinese pregnant women.